Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2026-02-20 @ 6:05 PM
Study NCT ID:
NCT02267603
Status:
COMPLETED
Last Update Posted:
2023-07-05
First Post:
2014-10-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-14
First Submit QC Date:
None
Study First Post Date:
2014-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-05
Results First Submit QC Date:
None
Results First Post Date:
2019-03-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-13
Last Update Post Date:
2023-07-05
Last Update Post Date Type:
ACTUAL